---
trial_id: 253
discovery_date: 2022-03-29 21:28:27.957414
date: 2022-03-29 21:28:27.957414
title: "A Phase 3 Open Label Study to Evaluate the Long-term Safety and Tolerability of ALKS 8700 in Adults with Relapsing Remitting Multiple Sclerosis"
summary: |
  <p>EudraCT Number: 2015-005160-41<br />Sponsor Protocol Number: ALK8700-A301<br />Sponsor Name: Biogen Idec Research Limited<br />Start Date: 2016-07-27<br />Medical condition: Relapsing Remitting Multiple Sclerosis<br />Disease: <br />Version: 21.1<br />SOC Term: 10029205 - Nervous system disorders<br />Classification Code: 10063399<br />Term: Relapsing-remitting multiple sclerosis<br />Level: PT<br /><br />Population Age: Adults, Elderly<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-005160-41/DE">DE</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-005160-41/BE">BE</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-005160-41/PL">PL</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-005160-41/ES">ES</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-005160-41/BG">BG</a> (Completed)</p>
link: 'https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-005160-41'
published_date: NaT
trial_source: Clinical Trials Register Europe
relevant: 
options:
  unlisted: false
---
<p>EudraCT Number: 2015-005160-41<br />Sponsor Protocol Number: ALK8700-A301<br />Sponsor Name: Biogen Idec Research Limited<br />Start Date: 2016-07-27<br />Medical condition: Relapsing Remitting Multiple Sclerosis<br />Disease: <br />Version: 21.1<br />SOC Term: 10029205 - Nervous system disorders<br />Classification Code: 10063399<br />Term: Relapsing-remitting multiple sclerosis<br />Level: PT<br /><br />Population Age: Adults, Elderly<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-005160-41/DE">DE</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-005160-41/BE">BE</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-005160-41/PL">PL</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-005160-41/ES">ES</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2015-005160-41/BG">BG</a> (Completed)</p>